Professor Elinor Sawyer
Consultant Clinical Oncologist
Research interests
- Cancer
Contact details
Biography
I am a Clinical Oncologist and specialise in the treatment of breast cancer. My research interests are genetic predisposition to breast cancer particularly lobular breast cancer and DCIS, and identification of biomarkers that predict progression of LCIS and DCIS.
I studied medicine at UCL and trained in oncology at the Middlesex, Royal Free and St Thomas’ Hospitals.
I undertook a PhD in Molecular and Population Genetics at the London Research Institute, Cancer Research UK.
Research
Breast Cancer Genetics
The Breast Cancer Genetics Research Group is focussed on the molecular genetics of invasive lobular breast cancer and in situ breast cancer and identification of biomarkers of progression to invasive disease.
Spatial Biology Network
The Spatial Biology Network is a cross-faculty research interest group that brings together researchers from various disciplines, ranging from technology development and molecular biology, to bioinformatics and clinical translational research, to explore the complexity of spatial biology.
News
Researchers' new DCIS discovery could help avoid unnecessary breast cancer treatment
A new study from a team of King’s researchers in the School of Cancer & Pharmaceutical Sciences, led by Professor Elinor Sawyer, has contradicted the view...
Research
Breast Cancer Genetics
The Breast Cancer Genetics Research Group is focussed on the molecular genetics of invasive lobular breast cancer and in situ breast cancer and identification of biomarkers of progression to invasive disease.
Spatial Biology Network
The Spatial Biology Network is a cross-faculty research interest group that brings together researchers from various disciplines, ranging from technology development and molecular biology, to bioinformatics and clinical translational research, to explore the complexity of spatial biology.
News
Researchers' new DCIS discovery could help avoid unnecessary breast cancer treatment
A new study from a team of King’s researchers in the School of Cancer & Pharmaceutical Sciences, led by Professor Elinor Sawyer, has contradicted the view...